Chen, Chih-Hao

Chen, San-Cher

Chuang, Hui-Ching

Chuang, Jiin-Haur

Du, Yung-Ying

Huang, Chao-Cheng

Kung, Mei-Lang

Tai, Ming-Hong

Wu, Chia-Ling

Journal of Biomedical Science

English

PubMed

Jiin-Haur Chuang

Hui-Ching Chuang

Chao-Cheng Huang

Chia-Ling Wu

Yung-Ying Du

Mei-Lang Kung

Chih-Hao Chen

San-Cher Chen

Ming-Hong Tai

Springer - Publisher Connector

Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells

Abstract
          
            Background
            Toll-like receptor-3 (TLR-3) is a critical component of innate immune system against dsRNA viruses and is expressed in the central nervous system. However, it remains unknown whether TLR3 may serve as a therapeutic target in human neuroblastoma (NB).
          
          
            Methods
            TLR3 expression in human NB samples was examined by immunohistochemical analysis. Quantitative RT-PCR and western blot was used to determine TLR3 expression in three human NB cell lines. The effect of TLR3 agonist, polyinosinic-polycytidylic acid (poly(I:C)), on the growth of human NB cells was evaluated by WST-1 cell proliferation assay, flow cytometry analysis, and immunoblot analysis. Blockade of TLR3 signaling was achieved using TLR3 neutralizing antibody, small interference RNA, and 2-aminopurine (2-AP), an inhibitor of protein kinase R (PKR), an interferon-induced, double-stranded RNA-activated protein kinase.
          
          
            Results
            In immunohistochemical studies, TLR3 mainly expressed in the cytoplasm of ganglion cells and in some neuroblastic cells, but not in the stromal cells in human NB tissues. Among three human NB cell lines analyzed, TLR3 was significantly up-regulated in SK-N-AS cells at mRNA and protein level compared with other two low TLR3- expressing NB cells. Treatment with poly(I:C) elicited significant growth inhibition and apoptosis only in high TLR3-expressing SK-N-AS cells, but not in low TLR3-expressing SK-N-FI and SK-N-DZ cells. Moreover, poly(I:C) treatment significantly stimulated the activities of PKR, interferon regulatory factor 3 (IRF-3) and caspase-3 in SK-N-AS cells. Application of TLR3 neutralizing antibody or small interference RNA (siRNA) reduced the poly(I:C)-induced inhibition of cell proliferation and apoptosis in SK-N-AS cells. On the contrary, ectopic TLR3 expression enhanced the sensitivity of low TLR3-expressing NB cells to poly(I:C). Finally, application of 2-AP attenuated the poly(I:C)-induced IRF-3 and caspase-3 activation in SK-N-AS cells.
          
          
            Conclusion
            The present study demonstrates that TLR3 is expressed in a subset of NB cells. Besides, TLR3/PKR/IRF-3/capase-3 pathway is implicated in the selective cytotoxicity of TLR3 agonist towards high TLR3-expressing NB cells.
          </jats:sec

Crossref

A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood

A: Toll, a muscle cell surface molecule, locally inhibits synaptic initiation of the RP3 motoneuron growth cone in Drosophila. Development

Aburatani H: Identification of Toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma. Clin Cancer Res

al: GRP78 expression correlates with histologic differentiation and favorable prognosis in neuroblastic tumors.

al: Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals.

Anthonsen MW: Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling.

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.

Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children’s cancer group study.

BR: Double-stranded RNA signals antiviral and inflammatory programs and dysfunctional glutamate transport in TLR3-expressing astrocytes. Glia

BR: Synergistic activation of innate immunity by doublestranded RNA and CpG DNA promotes enhanced antitumor activity. Cancer Res

CE: Induction of protein kinase PKR-dependent activation of interferon regulatory factor 3 by vaccinia virus occurs through adapter IPS-1 signaling.

CE: The RNA-activated protein kinase enhances the induction of interferon-beta and apoptosis mediated by cytoplasmic RNA sensors.

Development of TLR9 agonists for cancer therapy.

Double-stranded RNA induces an antiviral defense Chuang et al.

et al: Calreticulin expression in neuroblastoma–a novel independent prognostic factor. Ann Oncol

et al: Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study. Cancer Res

et al: Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry.

et al: Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.

H: TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.

JM: Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science

JR: TLR2 mediates neuroinflammation and neuronal damage.

Lancet

Lesniak MS: Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors. Glia

Llombart-Bosch A: Apoptosis in peripheral neuroblastic tumors. Immunohistochemical expression of bcl-2 and p53 is related to DNA fragmentation. Histol Histopathol

MK: IFN-alpha sensitizes human umbilical vein endothelial cells to apoptosis induced by doublestranded RNA.

Nakanuma Y: Innate immune response to double-stranded RNA in biliary epithelial cells is associated with the pathogenesis of biliary atresia. Hepatology

Pahlman S: High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma.

Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway.

Raschella G: Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line. Cell Growth Differ

Renno T: TLR3 can directly trigger apoptosis in human cancer cells.

SL: Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children’s Oncology Group. J Clin Oncol

T: Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis.

Taiwan Pediatric Oncology Group

The MYCN oncoprotein as a drug development target. Cancer Lett

Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin Cancer Res

Toll-like receptors in brain development and homeostasis. Sci STKE

Tsuchida Y: Implications of MYCN amplification in patients with stage 4 neuroblastoma who undergo intensive chemotherapy. J Pediatr Surg

YM: The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling.

file:///data/core-remote/dit/data/Springer-OA/pdf/574/aHR0cDovL2xpbmsuc3ByaW5nZXIuY29tLzEwLjExODYvMTQyMy0wMTI3LTE4LTY1LnBkZg==.pdf

Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells

Abstract

Similar works

Full text

Available Versions

Springer - Publisher Connector

Crossref